Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase C01.075: cruzipain

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, T Target, P Specificity, I Inhibitor, E Expression, U Therapeutic, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Cerutti,J.P., Diniz,L.A., Correa Santos,V., Vilchez Larrea,S.C., Alonso,G.D., Ferreira,R.S., Quevedo,M.A. and Dehaen,W.
    Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain
    ACS Med Chem Lett16, 72-79. PubMed  Europe PubMed DOI  I
  2. Sheu-Idrees,R., Marques,G.V.L., Santana,P.A.L., Diniz,L.A., Resende,D.M., Odoma,S., Olorunshola,O., Ferreira,R.S., Murta,S.M.F., Maltarollo,V.G. and de Oliveira,R.B.
    Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
    Mem Inst Oswaldo Cruz120, e240161-e240161. PubMed  Europe PubMed DOI  I
    3. 2024
  3. Cerutti,J.P., Diniz,L.A., Santos,V.C., Vilchez Larrea,S.C., Alonso,G.D., Ferreira,R.S., Dehaen,W. and Quevedo,M.A.
    Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain
    Molecules29, PubMed  Europe PubMed DOI
  4. Prates,J.L.B., Lopes,J.R., Chin,C.M., Ferreira,E.I., Dos Santos,J.L. and Scarim,C.B.
    Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruz
    Curr Med Chem31, 2285-2308. PubMed  Europe PubMed DOI  V
    5. 2023
  5. Santos,V.C., Leite,P.G., Santos,L.H., Pascutti,P.G., Kolb,P., Machado,F.S. and Ferreira,R.S.
    Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles
    Eur J Med Chem257, 115498-115498. PubMed  Europe PubMed DOI  I
    6. 2022
  6. de Oliveira,A.S., Valli,M., Ferreira,L.L., Souza,J.M., Krogh,R., Meier,L., Abreu,H.R., Voltolini,B.G., Llanes,L.C., Nunes,R.J., Braga,A.L. and Andricopulo,A.D.
    Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies
    Future Med Chem14, 795-808. PubMed  Europe PubMed DOI  I
  7. Reis,C.R.C.D., Souza,H.V.C.M., Leme,R.P.P., Castelo-Branco,F.S., Fernandes,T.V.A., Boechat,N., Dias,L.R.S. and Hoelz,L.V.B.
    Study of the dynamic behavior of the cruzain enzyme in free and complexed forms with competitive and noncovalent benzimidazole inhibitors
    J Biomol Struct Dyn1-15. PubMed  Europe PubMed DOI
  8. Santos,V.C. and Ferreira,R.S.
    Computational approaches towards the discovery and optimisation of cruzain inhibitors
    Mem Inst Oswaldo Cruz117, e210385-e210385. PubMed  Europe PubMed DOI  V
    9. 2021
  9. Barbosa da Silva,E., Rocha,D.A., Fortes,I.S., Yang,W., Monti,L., Siqueira-Neto,J.L., Caffrey,C.R., McKerrow,J., Andrade,S.F. and Ferreira,R.S.
    Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
    J Med Chem64, 13054-13071. PubMed  Europe PubMed DOI  I
  10. Santos Nascimento,I.J.D., de Aquino,T.M. and da Silva-Junior,E.F.
    Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases
    Curr Top Med Chem PubMed  Europe PubMed DOI  V
  11. Valois,M.V., de Oliveira,C., Lapa,A.J., Souccar,C. and Oliva,M.L.V.
    Bauhinia Protease Inhibitors Attenuate Gastric Ulcer by Blocking Neutrophil Enzymes
    Planta Med87, 169-176. PubMed  Europe PubMed DOI
    12. 2020
  12. Alvarez,V.E., Iribarren,P.A., Niemirowicz,G.T. and Cazzulo,J.J.
    Update on relevant trypanosome peptidases: Validated targets and future challenges
    Biochim Biophys Acta Proteins Proteom1869, 140577-140577. PubMed  Europe PubMed DOI
  13. Arafet,K., Gonzalez,F.V. and Moliner,V.
    Quantum mechanics/molecular mechanics studies of the mechanism of cysteine proteases inhibition by dipeptidyl nitroalkenes
    Chemistry26, 2002-2012. PubMed  Europe PubMed DOI  I
  14. Bonatto,V., Batista,P.H.J., Cianni,L., De Vita,D., Silva,D.G., Cedron,R., Tezuka,D.Y., de Albuquerque,S., Moraes,C.B., Franco,C.H., Lameira,J., Leitao,A. and Montanari,C.A.
    On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors
    RSC Med Chem11, 1275-1284. PubMed  Europe PubMed DOI  I
  15. Cerny,N., Bivona,A.E., Sanchez Alberti,A., Trinitario,S.N., Morales,C., Cardoso Landaburu,A., Cazorla,S.I. and Malchiodi,E.L.
    Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
    Front Immunol11, 565142-565142. PubMed  Europe PubMed DOI
  16. Chenna,B.C., Li,L., Mellott,D.M., Zhai,X., Siqueira-Neto,J.L., Calvet Alvarez,C., Bernatchez,J.A., Desormeaux,E., Alvarez Hernandez,E., Gomez,J., McKerrow,J.H., Cruz-Reyes,J. and Meek,T.D.
    Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect anti-trypanosomal activity
    J Med Chem63, 3298-3316. PubMed  Europe PubMed DOI  I
  17. Cianni,L., Rocho,F.D.R., Rosini,F., Bonatto,V., Ribeiro,J.F.R., Lameira,J., Leitao,A., Shamim,A. and Montanari,C.A.
    Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases
    Bioorg Chem101, 104039-104039. PubMed  Europe PubMed DOI  I
  18. Cianni,L., Lemke,C., Gilberg,E., Feldmann,C., Rosini,F., Rocho,F.D.R., Ribeiro,J.F.R., Tezuka,D.Y., Lopes,C.D., de Albuquerque,S., Bajorath,J., Laufer,S., Leitao,A., Gutschow,M. and Montanari,C.A.
    Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
    PLoS Negl Trop Dis14, e0007755-e0007755. PubMed  Europe PubMed DOI  I
  19. de Souza,M.L., de Oliveira Rezende Junior,C., Ferreira,R.S., Espinoza Chavez,R.M., Ferreira,L.L.G., Slafer,B.W., Magalhaes,L.G., Krogh,R., Oliva,G., Cruz,F.C., Dias,L.C. and Andricopulo,A.D.
    Discovery of potent, reversible and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach
    J Chem Inf Model60, 1028-1041. PubMed  Europe PubMed DOI  I
  20. Fonseca Lameiro,R.D., Shamim,A., Rosini,F., Cendron,R., Jatai Batista,P.H. and Montanari,C.A.
    Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds
    Future Med Chem PubMed  Europe PubMed DOI
  21. Ribeiro,J.F.R., Cianni,L., Li,C., Warwick,T.G., De Vita,D., Rosini,F., Dos Reis Rocho,F., Martins,F.C.P., Kenny,P.W., Lameira,J., Leitao,A., Emsley,J. and Montanari,C.A.
    Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor
    Bioorg Med Chem28, 115743-115743. PubMed  Europe PubMed DOI  I
  22. Silva,J.R.A., Cianni,L., Araujo,D., Batista,P.H.J., De Vita,D., Rosini,F., Leitao,A., Lameira,J. and Montanari,C.A.
    Assessment of the cruzain cysteine protease reversible and irreversible covalent inhibition mechanism
    J Chem Inf Model60, 1666-1677. PubMed  Europe PubMed DOI  I
  23. Toman,N.P., Kamenik,A.S., Santos,L.H., Hofer,F., Liedl,K.R. and Ferreira,R.S.
    Profiling selectivity of chagasin mutants towards cysteine proteases cruzain or cathepsin L through molecular dynamics simulations
    J Biomol Struct Dyn1-13. PubMed  Europe PubMed DOI
    24. 2019
  24. Barbosa da Silva,E., Dall,E., Briza,P., Brandstetter,H. and Ferreira,R.S.
    Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design
    Acta Crystallogr F Struct Biol Commun75, 419-427. PubMed  Europe PubMed DOI  S
  25. Bhowmick,S., Chorge,R.D., Jangam,C.S., Bharatrao,L.D., Patil,P.C., Chikhale,R.V. and Islam,M.A.
    Identification of potential cruzain inhibitors using de novo design, molecular docking and dynamics simulations studies
    J Biomol Struct Dyn1-11. PubMed  Europe PubMed DOI  I
  26. Boudreau,P.D., Miller,B.W., McCall,L.I., Almaliti,J., Reher,R., Hirata,K., Le,T., Siqueira-Neto,J.L., Hook,V. and Gerwick,W.H.
    Design of gallinamide A analogs as potent inhibitors of the cysteine proteases human cathepsin L and Trypanosoma cruzi cruzain
    J Med Chem62, 9026-9044. PubMed  Europe PubMed DOI  I
  27. Cianni,L., Feldmann,C.W., Gilberg,E., Gutschow,M., Juliano,L., Leitao,A., Bajorath,J. and Montanari,C.A.
    Can cysteine protease cross-class inhibitors achieve selectivity?
    J Med Chem62, 10497-10525. PubMed  Europe PubMed DOI  I
  28. Fabian,L., Martini,M.F., Sarduy,E.S., Estrin,D.A. and Moglioni,A.G.
    Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain
    Bioorg Med Chem Lett29, 2197-2202. PubMed  Europe PubMed DOI  I
  29. Ferreira,R.A.A., Pauli,I., Sampaio,T.S., de Souza,M.L., Ferreira,L.L.G., Magalhaes,L.G., Rezende CO Jr, Ferreira,R.S., Krogh,R., Dias,L.C. and Andricopulo,A.D.
    Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity
    Front Chem7, 798-798. PubMed  Europe PubMed DOI  I
  30. Gomes,J.C., Cianni,L., Ribeiro,J., Dos Reis Rocho,F., da Costa Martins Silva,S., Batista,P.H.J., Moraes,C.B., Franco,C.H., Freitas-Junior,L.H.G., Kenny,P.W., Leitao,A., Burtoloso,A.C.B., De Vita,D. and Montanari,C.A.
    Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement
    Bioorg Med Chem115083-115083. PubMed  Europe PubMed DOI  I
  31. Hernandez Alvarez,L., Barreto Gomes,D.E., Hernandez Gonzalez,J.E. and Pascutti,P.G.
    Dissecting a novel allosteric mechanism of cruzain: a computer-aided approach
    PLoS ONE14, e0211227-e0211227. PubMed  Europe PubMed DOI
  32. Herrera-Mayorga,V., Lara-Ramirez,E.E., Chacon-Vargas,K.F., Aguirre-Alvarado,C., Rodriguez-Paez,L., Alcantara-Farfan,V., Cordero-Martinez,J., Nogueda-Torres,B., Reyes-Espinosa,F., Bocanegra-Garcia,V. and Rivera,G.
    Structure-based virtual screening and in vitro evaluation of new Trypanosoma cruzi cruzain inhibitors
    Int J Mol Sci20, PubMed  Europe PubMed DOI  I
  33. Luchi,A.M., Villafane,R.N., Gomez Chavez,J.L., Bogado,M.L., Angelina,E.L. and Peruchena,N.M.
    Combining charge density analysis with machine learning tools to investigate the cruzain inhibition mechanism
    ACS Omega4, 19582-19594. PubMed  Europe PubMed DOI  I
  34. Monteiro,M.E., Lechuga,G., Lara,L.S., Souto,B.A., Vigano,M.G., Bourguignon,S.C., Calvet,C.M., Oliveira,F.O.R., Jr., Alves,C.R., Souza-Silva,F., Santos,M.S. and Pereira,M.C.S.
    Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease
    Eur J Med Chem182, 111610-111610. PubMed  Europe PubMed DOI  I
  35. Reyes-Espinosa,F., Juarez-Saldivar,A., Palos,I., Herrera-Mayorga,V., Garcia-Perez,C. and Rivera,G.
    In silico analysis of homologous heterodimers of cruzipain-chagasin from structural models built by homology
    Int J Mol Sci20, PubMed  Europe PubMed DOI
  36. Santos,L.H., Waldner,B.J., Fuchs,J.E., Pereira,G.A.N., Liedl,K.R., Caffarena,E.R. and Ferreira,R.S.
    Understanding structure-activity relationships for trypanosomal cysteine protease inhibitors by simulations and free energy calculations
    J Chem Inf Model59, 137-148. PubMed  Europe PubMed DOI  I
  37. Sartori,G.R., Leitao,A., Montanari,C.A. and Laughton,C.A.
    Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors
    PLoS ONE14, e0222055-e0222055. PubMed  Europe PubMed DOI  I
  38. Vieira,R.P., Santos,V.C. and Ferreira,R.S.
    Structure-based approaches targeting parasite cysteine proteases
    Curr Med Chem26, 4435-4453. PubMed  Europe PubMed DOI  I
    39. 2018
  39. Cianni,L., Sartori,G., Rosini,F., De Vita,D., Pires,G., Lopes,B.R., Leitao,A., Burtoloso,A.C.B. and Montanari,C.A.
    Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors
    Bioorg Chem79, 285-292. PubMed  Europe PubMed DOI  I
  40. da Silva-Junior,E.F., Barcellos Franca,P.H., Ribeiro,F.F., Bezerra Mendonca-Junior,F.J., Scotti,L., Scotti,M.T., de Aquino,T.M. and de Araujo-Junior,J.X.
    Molecular docking studies applied to a dataset of cruzain inhibitors
    Curr Comput Aided Drug Des14, 68-78. PubMed  Europe PubMed DOI  I
  41. Dos Santos,A.M., Cianni,L., De Vita,D., Rosini,F., Leitao,A., Laughton,C.A., Lameira,J. and Montanari,C.A.
    Experimental study and computational modelling of cruzain cysteine protease inhibition by dipeptidyl nitriles
    Phys Chem Chem Phys20, 24317-24328. PubMed  Europe PubMed DOI  I
  42. Giroud,M., Dietzel,U., Anselm,L., Banner,D., Kuglstatter,A., Benz,J., Blanc,J.B., Gaufreteau,D., Liu,H., Lin,X., Stich,A., Kuhn,B., Schuler,F., Kaiser,M., Brun,R., Schirmeister,T., Kisker,C., Diederich,F. and Haap,W.
    Repurposing a library of human cathepsin L ligands: identification of macrocyclic lactams as potent rhodesain and Trypanosoma brucei inhibitors
    J Med Chem61, 3350-3369. PubMed  Europe PubMed DOI  S  I
  43. Martins,L.C., Torres,P.H.M., de Oliveira,R.B., Pascutti,P.G., Cino,E.A. and Ferreira,R.S.
    Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations
    J Comput Aided Mol Des32, 591-605. PubMed  Europe PubMed DOI  I
  44. Rocha,D.A., Silva,E.B., Fortes,I.S., Lopes,M.S., Ferreira,R.S. and Andrade,S.F.
    Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
    Eur J Med Chem157, 1426-1459. PubMed  Europe PubMed DOI  I
  45. Royo,S., Schirmeister,T., Kaiser,M., Jung,S., Rodriguez,S., Bautista,J.M. and Gonzalez,F.V.
    Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates
    Bioorg Med Chem26, 4624-4634. PubMed  Europe PubMed DOI  I
  46. Salas-Sarduy,E., Landaburu,L.U., Karpiak,J., Madauss,K.P., Cazzulo,J.J., Aguero,F. and Alvarez,V.E.
    Author Correction: Novel scaffolds for inhibition of cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
    Sci Rep8, 8743-8743. PubMed  Europe PubMed DOI  I
  47. Saraiva,A.P.B., Miranda,R.M., Valente,R.P.P., Araujo,J.O., Souza,R.N.B., Costa,C.H.S., Oliveira,A.R.S., Almeida,M.O., Figueiredo,A.F., Ferreira,J.E.V., Alves,C.N. and Honorio,K.M.
    Molecular description of alpha-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics
    Chem Biol Drug Des92, 1475-1487. PubMed  Europe PubMed DOI  I
  48. Serrano,M., Gonzalez,V., Ray,S., Chavez,M.D. and Narayan,M.
    Identification of structure-stabilizing interactions in enzymes: a novel mechanism to impact enzyme activity
    Cell Biochem Biophys76, 59-71. PubMed  Europe PubMed DOI
  49. Zhai,X. and Meek,T.D.
    Catalytic mechanism of cruzain from Trypanosoma cruzi as determined from solvent kinetic isotope effects of steady-state and pre-steady-state kinetics
    Biochemistry57, 3176-3190. PubMed  Europe PubMed DOI
    50. 2017
  50. Braga,S.F., Martins,L.C., da Silva,E.B., Sales Junior,P.A., Murta,S.M., Romanha,A.J., Soh,W.T., Brandstetter,H., Ferreira,R.S. and de Oliveira,R.B.
    Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification
    Bioorg Med Chem25, 1889-1900. PubMed  Europe PubMed DOI  I
  51. Burtoloso,A.C., de Albuquerque,S., Furber,M., Gomes,J.C., Goncalez,C., Kenny,P.W., Leitao,A., Montanari,C.A., Quilles JC Junior, Ribeiro,J.F. and Rocha,J.R.
    Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
    PLoS Negl Trop Dis11, e0005343-e0005343. PubMed  Europe PubMed DOI  I
  52. de Souza,A.S., de Oliveira,M.T. and Andricopulo,A.D.
    Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies
    J Comput Aided Mol Des31, 801-816. PubMed  Europe PubMed DOI  I
  53. Ferreira,L.G. and Andricopulo,A.D.
    Targeting cysteine proteases in trypanosomatid disease drug discovery
    Pharmacol Ther180, 49-61. PubMed  Europe PubMed DOI  T
  54. Palos,I., Lara-Ramirez,E.E., Lopez-Cedillo,J.C., Garcia-Perez,C., Kashif,M., Bocanegra-Garcia,V., Nogueda-Torres,B. and Rivera,G.
    Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: virtual screening, In vitro and in vivo studies
    Molecules22, PubMed  Europe PubMed DOI  I
  55. Pauli,I., Ferreira,L.G., de Souza,M.L., Oliva,G., Ferreira,R.S., Dessoy,M.A., Slafer,B.W., Dias,L.C. and Andricopulo,A.D.
    Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors
    Future Med Chem9, 641-657. PubMed  Europe PubMed DOI  I
  56. Salas-Sarduy,E., Landaburu,L.U., Karpiak,J.X., Madauss,K.P., Cazzulo,J.J., Aguero,F. and Alvarez,V.E.
    Novel scaffolds for inhibition of cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
    Sci Rep7, 12073-12073. PubMed  Europe PubMed DOI  I
  57. Silva,D.G., Rocha,J.R., Sartori,G.R. and Montanari,C.A.
    Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors
    J Biomol Struct Dyn35, 3232-3249. PubMed  Europe PubMed DOI  I
  58. Silva,D.G., Ribeiro,J.F.R., De Vita,D., Cianni,L., Franco,C.H., Freitas-Junior,L.H., Moraes,C.B., Rocha,J.R., Burtoloso,A.C.B., Kenny,P.W., Leitao,A. and Montanari,C.A.
    A comparative study of warheads for design of cysteine protease inhibitors
    Bioorg Med Chem Lett27, 5031-5035. PubMed  Europe PubMed DOI  I
    59. 2016
  59. Cerny,N., Sanchez Alberti,A., Bivona,A.E., De Marzi,M.C., Frank,F.M., Cazorla,S.I. and Malchiodi,E.L.
    Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection
    Hum Vaccin Immunother12, 438-450. PubMed  Europe PubMed DOI  U
  60. de Moraes Gomes,P.A., de Oliveira Barbosa,M., Farias Santiago,E., de Oliveira Cardoso,M.V., Capistrano Costa,N.T., Hernandes,M.Z., Moreira,D.R., Da Silva,A.C., Dos Santos,T.A., Pereira,V.R., Brayner Dos Santosd,F.A., do Nascimento Pereira,G.A., Ferreira,R.S. and Leite,A.C.
    New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi
    Eur J Med Chem121, 387-398. PubMed  Europe PubMed DOI  I
  61. Ferrero,M.R., Heins,A.M., Soprano,L.L., Acosta,D.M., Esteva,M.I., Jacobs,T. and Duschak,V.G.
    Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E
    Med Microbiol Immunol205, 21-35. PubMed  Europe PubMed DOI
  62. Hoelz,L.V., Leal,V.F., Rodrigues,C.R., Pascutti,P.G., Albuquerque,M.G., Muri,E.M. and Dias,L.R.
    Molecular dynamics simulations of the free and inhibitor-bound cruzain systems in aqueous solvent: insights on the inhibition mechanism in acidic pH
    J Biomol Struct Dyn34, 1969-1978. PubMed  Europe PubMed DOI
  63. Jefferson,T., McShan,D., Warfield,J. and Ogungbe,I.V.
    Screening and identification of inhibitors of Trypanosoma brucei cathepsin L with antitrypanosomal activity
    Chem Biol Drug Des87, 154-158. PubMed  Europe PubMed DOI  I
  64. Latorre,A., Schirmeister,T., Kesselring,J., Jung,S., Johe,P., Hellmich,U.A., Heilos,A., Engels,B., Krauth-Siegel,R.L., Dirdjaja,N., Bou-Iserte,L., Rodriguez,S. and Gonzalez,F.V.
    Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain
    ACS Med Chem Lett7, 1073-1076. PubMed  Europe PubMed DOI  I
  65. Sbaraglini,M.L., Bellera,C.L., Fraccaroli,L., Larocca,L., Carrillo,C., Talevi,A. and Alba Soto,C.D.
    Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease
    Int J Antimicrob Agents48, 91-95. PubMed  Europe PubMed DOI  I
  66. Silva-Junior,E.F., Silva,E.P., Franca,P.H., Silva,J.P., Barreto,E.O., Silva,E.B., Ferreira,R.S., Gatto,C.C., Moreira,D.R., Siqueira-Neto,J.L., Mendonca-Junior,F.J., Lima,M.C., Bortoluzzi,J.H., Scotti,M.T., Scotti,L., Meneghetti,M.R., Aquino,T.M. and Araujo-Junior,J.X.
    Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi
    Bioorg Med Chem24, 4228-4240. PubMed  Europe PubMed DOI  I
    67. 2015
  67. Arafet,K., Ferrer,S. and Moliner,V.
    First quantum mechanics/molecular mechanics studies of the inhibition mechanism of cruzain by peptidyl halomethyl ketones
    Biochemistry54, 3381-3391. PubMed  Europe PubMed DOI  I
  68. Avelar,L.A., Camilo,C.D., de Albuquerque,S., Fernandes,W.B., Goncalez,C., Kenny,P.W., Leitao,A., McKerrow,J.H., Montanari,C.A., Orozco,E.V., Ribeiro,J.F., Rocha,J.R., Rosini,F. and Saidel,M.E.
    Molecular design, synthesis and trypanocidal activity of dipeptidyl nitriles as cruzain inhibitors
    PLoS Negl Trop Dis9, e0003916-e0003916. PubMed  Europe PubMed DOI  I
  69. Branquinha,M.H., Oliveira,S.S., Sangenito,L.S., Sodre,C.L., Kneipp,L.F., D'Avila-Levy,C.M. and Santos,A.L.
    Cruzipain: an update on its potential as chemotherapy target against the human pathogen Trypanosoma cruzi
    Curr Med Chem22, 2225-2235. PubMed  Europe PubMed  V
  70. de Almeida,L., Alves,K.F., Maciel-Rezende,C.M., Jesus Lde,O., Pires,F.R., Junior,C.V., Izidoro,M.A., Judice,W.A., Dos Santos,M.H. and Marques,M.J.
    Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania(L.) amazonensis amastigotes
    Biomed Pharmacother75, 93-99. PubMed  Europe PubMed DOI  I
  71. Espindola,J.W., Cardoso,M.V., Filho,G.B., Oliveira E Silva,D.A., Moreira,D.R., Bastos,T.M., Simone,C.A., Soares,M.B., Villela,F.S., Ferreira,R.S., Castro,M.C., Pereira,V.R., Murta,S.M., Sales Junior,P.A., Romanha,A.J. and Leite,A.C.
    Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain
    Eur J Med Chem101, 818-835. PubMed  Europe PubMed DOI  I
  72. Ferrao,P.M., D'Avila-Levy,C.M., Araujo-Jorge,T.C., Degrave,W.M., Goncalves,A.S., Garzoni,L.R., Lima,A.P., Feige,J.J., Bailly,S., Mendonca-Lima,L. and Waghabi,M.C.
    Cruzipain activates latent TGF-beta from host cells during T. cruzi invasion
    PLoS ONE10, e0124832- PubMed  Europe PubMed DOI  I
  73. Fonseca,N.C., da Cruz,L.F., da Silva Villela,F., do Nascimento Pereira,G.A., de Siqueira-Neto,J.L., Kellar,D., Suzuki,B.M., Ray,D., de Souza,T.B., Alves,R.J., Junior,P.A., Romanha,A.J., Murta,S.M., McKerrow,J.H., Caffrey,C.R., de Oliveira,R.B. and Ferreira,R.S.
    Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1
    Antimicrob Agents Chemother59, 2666-2677. PubMed  Europe PubMed DOI  I
  74. Martinez-Mayorga,K., Byler,K.G., Ramirez-Hernandez,A.I. and Terrazas-Alvares,D.E.
    Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
    Drug Discov Today20, 890-898. PubMed  Europe PubMed DOI  I
  75. Neitz,R.J., Bryant,C., Chen,S., Gut,J., Hugo Caselli,E., Ponce,S., Chowdhury,S., Xu,H., Arkin,M.R., Ellman,J.A. and Renslo,A.R.
    Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease
    Bioorg Med Chem Lett25, 4834-4837. PubMed  Europe PubMed DOI  I
    76. 2014
  76. Batista,C.M., Medeiros,L.C., Eger,I. and Soares,M.J.
    mAb CZP-315.D9: an antirecombinant cruzipain monoclonal antibody that specifically labels the reservosomes of Trypanosoma cruzi epimastigotes
    Biomed Res Int2014, 714749-714749. PubMed  Europe PubMed DOI
  77. Ferreira,R.S., Dessoy,M.A., Pauli,I., Souza,M.L., Krogh,R., Sales,A.I., Oliva,G., Dias,L.C. and Andricopulo,A.D.
    Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents
    J Med Chem57, 2380-2392. PubMed  Europe PubMed DOI  I
  78. Maeda,F.Y., Cortez,C., Izidoro,M.A., Juliano,L. and Yoshida,N.
    Fibronectin-degrading activity of Trypanosoma cruzi cysteine proteinase plays a role in host cell invasion
    Infect Immun82, 5166-5174. PubMed  Europe PubMed DOI
  79. Miao,Q., Santamaria,C., Bailey,D., Genest,J., Ward,B.J. and Ndao,M.
    Apolipoprotein A-I truncations in Chagas disease are caused by cruzipain, the major cysteine protease of Trypanosoma cruzi
    Am J Pathol184, 976-984. PubMed  Europe PubMed DOI
  80. Ndao,M., Beaulieu,C., Black,W.C., Isabel,E., Vasquez-Camargo,F., Nath-Chowdhury,M., Masse,F., Mellon,C., Methot,N. and Nicoll-Griffith,D.A.
    Reversible cysteine protease inhibitors show promise for a Chagas disease cure
    Antimicrob Agents Chemother58, 1167-1178. PubMed  Europe PubMed DOI  I
  81. Rodrigues,A.C., Ortiz,P.A., Costa-Martins,A.G., Neves,L., Garcia,H.A., Alves,J.M., Camargo,E.P., Alfieri,S.C., Gibson,W. and Teixeira,M.M.
    Congopain genes diverged to become specific to Savannah, Forest and Kilifi subgroups of Trypanosoma congolense, and are valuable for diagnosis, genotyping and phylogenetic inferences
    Infect Genet Evol23, 20-31. PubMed  Europe PubMed DOI
    82. 2013
  82. Assis,D.M., Gontijo,V.S., de Oliveira Pereira,I., Santos,J.A., Camps,I., Nagem,T.J., Ellena,J., Izidoro,M.A., Dos Santos Tersariol,I.L., de Barros,N.M., Doriguetto,A.C., Dos Santos,M.H. and Juliano,M.A.
    Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
    J Enzyme Inhib Med Chem28, 661-670. PubMed  Europe PubMed DOI  S  I
  83. Bellera,C.L., Balcazar,D.E., Alberca,L., Labriola,C.A., Talevi,A. and Carrillo,C.
    Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects
    J Chem Inf Model53, 2402-2408. PubMed  Europe PubMed DOI  I
  84. Ponce,N.E., Carrera-Silva,E.A., Pellegrini,A.V., Cazorla,S.I., Malchiodi,E.L., Lima,A.P., Gea,S. and Aoki,M.P.
    Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells
    Biochim Biophys Acta1832, 485-494. PubMed  Europe PubMed DOI
  85. Wiggers,H.J., Rocha,J.R., Fernandes,W.B., Sesti-Costa,R., Carneiro,Z.A., Cheleski,J., Da Silva,A.B., Juliano,L., Cezari,M.H., Silva,J.S., McKerrow,J.H. and Montanari,C.A.
    Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay
    PLoS Negl Trop Dis7, e2370-e2370. PubMed  Europe PubMed DOI  I
    86. 2012
  86. Alvarez,V.E., Niemirowicz,G.T. and Cazzulo,J.J.
    The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
    Biochim Biophys Acta1824, 195-206. PubMed  Europe PubMed DOI  V
  87. Cazzulo,J.J.
    Cruzipain
    [ISSN:978-0-12-407743-0]3, 1913-1918. DOI
  88. Lavrado,J., Mackey,Z., Hansell,E., McKerrow,J.H., Paulo,A. and Moreira,R.
    Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives
    Bioorg Med Chem Lett22, 6256-6260. PubMed  Europe PubMed DOI  I
  89. Lee,G.M., Balouch,E., Goetz,D.H., Lazic,A., McKerrow,J.H. and Craik,C.S.
    Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy
    Biochemistry51, 10087-10098. PubMed  Europe PubMed DOI  E  S  I
  90. Lima,L., Ortiz,P.A., da Silva,F.M., Alves,J.M., Serrano,M.G., Cortez,A.P., Alfieri,S.C., Buck,G.A. and Teixeira,M.M.
    Repertoire, genealogy and genomic organization of cruzipain and homologous genes in Trypanosoma cruzi, T. cruzi-like and other trypanosome species
    PLoS ONE7, e38385-e38385. PubMed  Europe PubMed DOI
  91. Lozano,N.B., Maltarollo,V.G., Weber,K.C., Honorio,K.M., Guido,R.V., Andricopulo,A.D. and Da Silva,A.B.
    Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies
    Med Chem8, 1045-1056. PubMed  Europe PubMed  I
  92. Mendez-Lucio,O., Romo-Mancillas,A., Medina-Franco,J.L. and Castillo,R.
    Computational study on the inhibition mechanism of cruzain by nitrile-containing molecules
    J Mol Graph Model35, 28-35. PubMed  Europe PubMed DOI  I
  93. Rogers,K.E., Keranen,H., Durrant,J.D., Ratnam,J., Doak,A., Arkin,M.R. and McCammon,J.A.
    Novel cruzain inhibitors for the treatment of Chagas' disease
    Chem Biol Drug Des80, 398-405. PubMed  Europe PubMed DOI  I
  94. Uehara,L.A., Moreira,O.C., Oliveira,A.C., Azambuja,P., Lima,A.P., Britto,C., Dos Santos,A.L., Branquinha,M.H. and D'Avila-Levy,C.M.
    Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut
    PLoS Negl Trop Dis6, e1958-e1958. PubMed  Europe PubMed DOI
  95. Yang,P.Y., Wang,M., Li,L., Wu,H., He,C.Y. and Yao,S.Q.
    Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents
    Chemistry18, 6528-6541. PubMed  Europe PubMed DOI  I
    96. 2011
  96. Acosta,D.M., Soprano,L.L., Ferrero,M., Landoni,M., Esteva,M.I., Couto,A.S. and Duschak,V.G.
    A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin
    Parasite Immunol33, 363-370. PubMed  Europe PubMed DOI
  97. Boulange,A.F., Khamadi,S.A., Pillay,D., Coetzer,T.H. and Authie,E.
    Production of congopain, the major cysteine protease of Trypanosoma (Nannomonas) congolense, in Pichia pastoris reveals unexpected dimerisation at physiological pH
    Protein Expr Purif75, 95-103. PubMed  Europe PubMed DOI  E
  98. Caffrey,C.R., Lima,A.P. and Steverding,D.
    Cysteine peptidases of kinetoplastid parasites
    Adv Exp Med Biol712, 84-99. PubMed  Europe PubMed DOI  V
  99. Caputto,M.E., Fabian,L.E., Benitez,D., Merlino,A., Rios,N., Cerecetto,H., Moltrasio,G.Y., Moglioni,A.G., Gonzalez,M. and Finkielsztein,L.M.
    Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents
    Bioorg Med Chem19, 6818-6826. PubMed  Europe PubMed DOI  I
  100. Doyle,P.S., Zhou,Y.M., Hsieh,I., Greenbaum,D.C., McKerrow,J.H. and Engel,J.C.
    The Trypanosoma cruzi protease cruzain mediates immune evasion
    PLoS Pathog7, e1002139-e1002139. PubMed  Europe PubMed DOI
  101. Sajid,M., Robertson,S.A., Brinen,L.S. and McKerrow,J.H.
    Cruzain : the path from target validation to the clinic
    Adv Exp Med Biol712, 100-115. PubMed  Europe PubMed DOI  V
    102. 2010
  102. Beaulieu,C., Isabel,E., Fortier,A., Masse,F., Mellon,C., Methot,N., Ndao,M., Nicoll-Griffith,D., Lee,D., Park,H. and Black,W.C.
    Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
    Bioorg Med Chem Lett20, 7444-7449. PubMed  Europe PubMed DOI  I
  103. Benitez-Hernandez,I., Mendez-Enriquez,E., Ostoa,P., Fortoul,T., Ramirez,J.A., Stempin,C., Cerban,F., Soldevila,G. and Garcia-Zepeda,E.A.
    Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists
    Immunobiology215, 413-426. PubMed  Europe PubMed DOI
  104. Brak,K., Kerr,I.D., Barrett,K.T., Fuchi,N., Debnath,M., Ang,K., Engel,J.C., McKerrow,J.H., Doyle,P.S., Brinen,L.S. and Ellman,J.A.
    Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy
    J Med Chem53, 1763-1773. PubMed  Europe PubMed DOI  I
  105. Cazorla,S.I., Frank,F.M., Becker,P.D., Arnaiz,M., Mirkin,G.A., Corral,R.S., Guzman,C.A. and Malchiodi,E.L.
    Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection
    J Infect Dis202, 136-144. PubMed  Europe PubMed DOI
  106. Durrant,J.D., Keranen,H., Wilson,B.A. and McCammon,J.A.
    Computational identification of uncharacterized cruzain binding sites
    PLoS Negl Trop Dis4, e676-e676. PubMed  Europe PubMed DOI
  107. Ferreira,R.S., Simeonov,A., Jadhav,A., Eidam,O., Mott,B.T., Keiser,M.J., McKerrow,J.H., Maloney,D.J., Irwin,J.J. and Shoichet,B.K.
    Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
    J Med Chem53, 4891-4905. PubMed  Europe PubMed DOI  I
  108. Luci,D., Lea,W., Ferreira,R., Shoichet,B., Simeonov,A., Rodriguez,A., Jadhav,A. and Maloney,D.J.
    Reversible and non-covalent benzimidazole-based in vivo lead for Chagas disease
    [ISSN:NBK133417] PubMed  Europe PubMed  I
  109. Mott,B.T., Ferreira,R.S., Simeonov,A., Jadhav,A., Ang,K.K., Leister,W., Shen,M., Silveira,J.T., Doyle,P.S., Arkin,M.R., McKerrow,J.H., Inglese,J., Austin,C.P., Thomas,C.J., Shoichet,B.K. and Maloney,D.J.
    Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB
    J Med Chem53, 52-60. PubMed  Europe PubMed DOI  S  I
  110. Pillay,D., Boulange,A.F. and Coetzer,T.H.
    Expression, purification and characterisation of two variant cysteine peptidases from Trypanosoma congolense with active site substitutions
    Protein Expr Purif74, 264-271. PubMed  Europe PubMed DOI
  111. Rodrigues,G.C., Aguiar,A.P., da Silva Goncalves Vianez Jr., Macrae,A., De Melo,A.C.N. and Vermelho,A.B.
    Peptidase inhibitors as a possible therapeutic strategy for Chagas disease
    Curr Enzyme Inhib6, 183-194. DOI  I
    112. 2009
  112. Bryant,C., Kerr,I.D., Debnath,M., Ang,K.K., Ratnam,J., Ferreira,R.S., Jaishankar,P., Zhao,D., Arkin,M.R., McKerrow,J.H., Brinen,L.S. and Renslo,A.R.
    Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases
    Bioorg Med Chem Lett19, 6218-6221. PubMed  Europe PubMed DOI  S  I
  113. Caffrey,C.R. and Steverding,D.
    Kinetoplastid papain-like cysteine peptidases
    Mol Biochem Parasitol167, 12-19. PubMed  Europe PubMed DOI  I
  114. dos Santos Filho,J.M., Leite,A.C., de Oliveira,B.G., Moreira,D.R., Lima,M.S., Soares,M.B. and Leite,L.F.
    Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents
    Bioorg Med Chem17, 6682-6691. PubMed  Europe PubMed DOI  I
  115. Duschak,V.G. and Couto,A.S.
    Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review
    Curr Med Chem16, 3174-3202. PubMed  Europe PubMed DOI  V
  116. Ferreira,R.S., Bryant,C., Ang,K.K., McKerrow,J.H., Shoichet,B.K. and Renslo,A.R.
    Divergent modes of enzyme inhibition in a homologous structure-activity series
    J Med Chem52, 5005-5008. PubMed  Europe PubMed DOI  I
  117. Huson,L.E., Authie,E., Boulange,A.F., Goldring,J.P. and Coetzer,T.H.
    Modulation of the immunogenicity of the Trypanosoma congolense cysteine protease, congopain, through complexation with alpha(2)-macroglobulin
    Vet Res40, 52-52. PubMed  Europe PubMed DOI
  118. Kerr,I.D., Lee,J.H., Farady,C.J., Marion,R., Rickert,M., Sajid,M., Pandey,K.C., Caffrey,C.R., Legac,J., Hansell,E., McKerrow,J.H., Craik,C.S., Rosenthal,P.J. and Brinen,L.S.
    Vinyl sulfones as antiparasitic agents and a structural basis for drug design
    J Biol Chem284, 25697-25703. PubMed  Europe PubMed DOI  S  I
  119. Romeiro,N.C., Aguirre,G., Hernandez,P., Gonzalez,M., Cerecetto,H., Aldana,I., Perez-Silanes,S., Monge,A., Barreiro,E.J. and Lima,L.M.
    Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates
    Bioorg Med Chem17, 641-652. PubMed  Europe PubMed DOI  I
    120. 2008
  120. Acosta,D.M., Arnaiz,M.R., Esteva,M.I., Barboza,M., Stivale,D., Orlando,U.D., Torres,S., Laucella,S.A., Couto,A.S. and Duschak,V.G.
    Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice
    Int Immunol20, 461-470. PubMed  Europe PubMed DOI
  121. Brak,K., Doyle,P.S., McKerrow,J.H. and Ellman,J.A.
    Identification of a new class of nonpeptidic inhibitors of cruzain
    J Am Chem Soc130, 6404-6410. PubMed  Europe PubMed DOI  I
  122. Cazorla,S.I., Frank,F.M., Becker,P.D., Corral,R.S., Guzman,C.A. and Malchiodi,E.L.
    Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model
    Vaccine26, 1999-2009. PubMed  Europe PubMed DOI
  123. Chen,Y.T., Lira,R., Hansell,E., McKerrow,J.H. and Roush,W.R.
    Synthesis of macrocyclic trypanosomal cysteine protease inhibitors
    Bioorg Med Chem Lett18, 5860-5863. PubMed  Europe PubMed DOI  I
  124. Frank,F.M., Cazorla,S.I., Sartori,M.J. and Corral,R.S.
    Elicitation of specific, Th1-biased immune response precludes skeletal muscle damage in cruzipain-vaccinated mice
    Exp Mol Pathol84, 64-70. PubMed  Europe PubMed DOI
  125. Freitas,R.F., Oprea,T.I. and Montanari,C.A.
    2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L
    Bioorg Med Chem16, 838-853. PubMed  Europe PubMed DOI  I
  126. Guido,R.V., Trossini,G.H., Castilho,M.S., Oliva,G., Ferreira,E.I. and Andricopulo,A.D.
    Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi
    J Enzyme Inhib Med Chem23, 964-973. PubMed  Europe PubMed DOI  I
  127. Jaishankar,P., Hansell,E., Zhao,D.M., Doyle,P.S., McKerrow,J.H. and Renslo,A.R.
    Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes
    Bioorg Med Chem Lett18, 624-628. PubMed  Europe PubMed DOI  I
  128. Scharfstein,J. and Lima,A.P.
    Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi
    Subcell Biochem47, 140-154. PubMed  Europe PubMed DOI
  129. Zanatta,N., Amaral,S.S., Dos Santos,J.M., de Mello,D.L., Fernandes,L., Bonacorso,H.G., Martins,M.A., Andricopulo,A.D. and Borchhardt,D.M.
    Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines
    Bioorg Med Chem16, 10236-10243. PubMed  Europe PubMed DOI  I
    130. 2007
  130. Doyle,P.S., Zhou,Y.M., Engel,J.C. and McKerrow,J.H.
    A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
    Antimicrob Agents Chemother51, 3932-3939. PubMed  Europe PubMed DOI  I
  131. Gonzalez,F.V., Izquierdo,J., Rodriguez,S., McKerrow,J.H. and Hansell,E.
    Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain
    Bioorg Med Chem Lett17, 6697-6700. PubMed  Europe PubMed DOI  I
  132. Leite,A.C., Moreira,D.R., Cardoso,M.V., Hernandes,M.Z., Alves Pereira,V.R., Silva,R.O., Kiperstok,A.C., Lima,M. and Soares,M.B.
    Synthesis, cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi
    ChemMedChem2, 1339-1345. PubMed  Europe PubMed DOI  I
  133. Reis,F.C., Costa,T.F., Sulea,T., Mezzetti,A., Scharfstein,J., Bromme,D., Menard,R. and Lima,A.P.
    The propeptide of cruzipain - a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F
    FEBS J274, 1224-1234. PubMed  Europe PubMed DOI
    134. 2006
  134. [YEAR:6-3-2006]Choe,Y., Leonetti,F., Greenbaum,D.C., Lecaille,F., Bogyo,M., Bromme,D., Ellman,J.A. and Craik,C.S.
    Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
    J Biol Chem281, 12824-12832. PubMed  Europe PubMed DOI  P
  135. Gea,S., Guinazu,N., Pellegrini,A., Carrera Silva,E.A., Giordanengo,L., Cano,R. and Aoki,M.P.
    Cruzipain, a major Trypanosoma cruzi cystein protease in the host-parasite interplay
    Inmunologia25, 225-238.  V
    136. 2005
  136. Barboza,M., Duschak,V.G., Fukuyama,Y., Nonami,H., Erra-Balsells,R., Cazzulo,J.J. and Couto,A.S.
    Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides
    FEBS J272, 3803-3815. PubMed  Europe PubMed DOI
  137. Barr,S.C., Warner,K.L., Kornreic,B.G., Piscitelli,J., Wolfe,A., Benet,L. and McKerrow,J.H.
    A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi
    Antimicrob Agents Chemother49, 5160-5161. PubMed  Europe PubMed DOI  I
  138. [YEAR:15-3-2005]Choe,Y., Brinen,L.S., Price,M.S., Engel,J.C., Lange,M., Grisostomi,C., Weston,S.G., Pallai,P.V., Cheng,H., Hardy,L.W., Hartsough,D.S., McMakin,M., Tilton,R.F., Baldino,C.M. and Craik,C.S.
    Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
    Bioorg Med Chem13, 2141-2156. PubMed  Europe PubMed DOI  S  I
  139. [YEAR:3-1-2005]Fujii,N., Mallari,J.P., Hansell,E.J., Mackey,Z., Doyle,P., Zhou,Y.M., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Guy,R.K.
    Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
    Bioorg Med Chem Lett15, 121-123. PubMed  Europe PubMed DOI  I
  140. [YEAR:9-8-2005]Godat,E., Chowdhury,S., Lecaille,F., Belghazi,M., Purisima,E.O. and Lalmanach,G.
    Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor
    Biochemistry44, 10486-10493. PubMed  Europe PubMed DOI
  141. [YEAR:1-3-2005]Polticelli,F., Zaini,G., Bolli,A., Antonini,G., Gradoni,L. and Ascenzi,P.
    Probing the cruzain S2 recognition subsite: a kinetic and binding energy calculation study
    Biochemistry44, 2781-2789. PubMed  Europe PubMed DOI
    142. 2004
  142. Aparicio,I.M., Scharfstein,J. and Lima,A.P.
    A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes
    Infect Immun72, 5892-5902. PubMed  Europe PubMed DOI
  143. [YEAR:12-3-2004]Bocedi,A., Gradoni,L., Menegatti,E. and Ascenzi,P.
    Kinetics of parasite cysteine proteinase inactivation by NO-donors
    Biochem Biophys Res Commun315, 710-718. PubMed  Europe PubMed DOI
  144. Cazzulo,J.J.
    Cruzipain
    [ISSN:0-12-079610-4]2, 1160-1163.  V
  145. Judice,W.A., Puzer,L., Cotrin,S.S., Carmona,A.K., Coombs,G.H., Juliano,L. and Juliano,M.A.
    Carboxydipeptidase activities of recombinant cysteine peptidases. Cruzain of Trypanosoma cruzi and CPB of Leishmania mexicana
    Eur J Biochem271, 1046-1053. PubMed  Europe PubMed DOI  P
  146. Rossi,A., Deveraux,Q., Turk,B. and Sali,A.
    Comprehensive search for cysteine cathepsins in the human genome
    Biol Chem385, 363-372. PubMed  Europe PubMed DOI
    147. 2003
  147. [YEAR:11-8-2003]Berasain,P., Carmona,C., Frangione,B., Cazzulo,J.J. and Goni,F.
    Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    Mol Biochem Parasitol130, 23-29. PubMed  Europe PubMed DOI
  148. Chibale,K. and Musonda,C.C.
    The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors
    Curr Med Chem10, 1863-1889. PubMed  Europe PubMed DOI  I
  149. [YEAR:20-10-2003]Chiyanzu,I., Hansell,E., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Chibale,K.
    Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain
    Bioorg Med Chem Lett13, 3527-3530. PubMed  Europe PubMed DOI  I
  150. Huang,L., Brinen,L.S. and Ellman,J.A.
    Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain
    Bioorg Med Chem11, 21-29. PubMed  Europe PubMed DOI  S  I
    151. 2002
  151. Alvarez,V., Parussini,F., Aslund,L. and Cazzulo,J.J.
    Expression in insect cells of active mature cruzipain from Trypanosoma cruzi, containing its C-terminal domain
    Protein Expr Purif26, 467-475. PubMed  Europe PubMed DOI  E
  152. [YEAR:20-6-2002]Du,X., Guo,C., Hansell,E., Doyle,P.S., Caffrey,C.R., Holler,T.P., McKerrow,J.H. and Cohen,F.E.
    Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain
    J Med Chem45, 2695-2707. PubMed  Europe PubMed DOI  I
  153. [YEAR:31-1-2002]Huang,L., Lee,A. and Ellman,J.A.
    Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis
    J Med Chem45, 676-684. PubMed  Europe PubMed DOI  I
  154. [YEAR:21-10-2002]Huang,L. and Ellman,J.A.
    General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain
    Bioorg Med Chem Lett12, 2993-2996. PubMed  Europe PubMed DOI  I
  155. Lalmanach,G., Boulange,A., Serveau,C., Lecaille,F., Scharfstein,J., Gauthier,F. and Authie,E.
    Congopain from Trypanosoma congolense: drug target and vaccine candidate
    Biol Chem383, 739-749. PubMed  Europe PubMed DOI
  156. [YEAR:22-2-2002]Lima,A.P., Almeida,P.C., Tersariol,I.L., Schmitz,V., Schmaier,A.H., Juliano,L., Hirata,I.Y., Muller-Esterl,W., Chagas,J.R. and Scharfstein,J.
    Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain
    J Biol Chem277, 5875-5881. PubMed  Europe PubMed DOI
  157. [YEAR:3-6-2002]Rodrigues,C.R., Flaherty,T.M., Springer,C., McKerrow,J.H. and Cohen,F.E.
    CoMFA and HQSAR of acylhydrazide cruzain inhibitors
    Bioorg Med Chem Lett12, 1537-1541. PubMed  Europe PubMed DOI  I
    158. 2001
  158. Alves,L.C., Melo,R.L., Cezari,M.H., Sanderson,S.J., Mottram,J.C., Coombs,G.H., Juliano,L. and Juliano,M.A.
    Analysis of the S(2) subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids
    Mol Biochem Parasitol117, 137-143. PubMed  Europe PubMed DOI  P
  159. Cazzulo,J.J., Stoka,V. and Turk,V.
    The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease
    Curr Pharm Des7, 1143-1156. PubMed  Europe PubMed DOI
  160. de Oliveira,C., Santana,L.A., Carmona,A.K., Cezari,M.H., Sampaio,M.U., Sampaio,C.A.M. and Oliva,M.L.V.
    Structure of cruzipain/cruzain inhibitors isolated from Bauhinia bauhinioides seeds
    Biol Chem382, 847-852. PubMed  Europe PubMed DOI
  161. Judice,W.A.S., Cezari,M.H.S., Lima,A.P.C.A., Scharfstein,J., Chagas,J.R., Tersariol,I.L.S., Juliano,M.A. and Juliano,L.
    Comparison of the specificity, stability and individual rate constants with respective activation parameters for the peptidase activity of cruzipain and its recombinant form, cruzain, from Trypanosoma cruzi
    Eur J Biochem268, 6578-6586. PubMed  Europe PubMed DOI
  162. [YEAR:2-11-2001]Lecaille,F., Cotton,J., McKerrow,J.H., Ferrer-Di Martino,M., Boll-Bataille,E., Gauthier,F. and Lalmanach,G.
    Reversible inhibition of cathepsin L-like proteases by 4-mer pseudopeptides
    FEBS Lett507, 362-366. PubMed  Europe PubMed DOI
  163. Lecaille,F., Authie,E., Moreau,T., Serveau,C., Gauthier,F. and Lalmanach,G.
    Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids
    Eur J Biochem268, 2733-2741. PubMed  Europe PubMed DOI
  164. [YEAR:25-4-2001]Lima,A.P., dos Reis,F.C., Serveau,C., Lalmanach,G., Juliano,L., Menard,R., Vernet,T., Thomas,D.Y., Storer,A.C. and Scharfstein,J.
    Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors
    Mol Biochem Parasitol114, 41-52. PubMed  Europe PubMed DOI  I
  165. Monteiro,A.C., Abrahamson,M., Lima,A.P., Vannier-Santos,M.A. and Scharfstein,J.
    Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi
    J Cell Sci114, 3933-3942. PubMed  Europe PubMed
  166. [YEAR:22-10-2001]Roush,W.R., Cheng,J., Knapp-Reed,B., Alvarez-Hernandez,A., McKerrow,J.H., Hansell,E. and Engel,J.C.
    Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain
    Bioorg Med Chem Lett11, 2759-2762. PubMed  Europe PubMed DOI  I
  167. Salvati,L., Mattu,M., Polticelli,F., Tiberi,F., Gradoni,L., Venturini,G., Bolognesi,M. and Ascenzi,P.
    Modulation of the catalytic activity of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, by temperature and pH
    Eur J Biochem268, 3253-3258. PubMed  Europe PubMed DOI
    168. 2000
  168. [YEAR:15-8-2000]Brinen,L.S., Hansell,E., Cheng,J., Roush,W.R., McKerrow,J.H. and Fletterick,R.J.
    A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease
    Structure8, 831-840. PubMed  Europe PubMed DOI
  169. [YEAR:5-7-2000]Harris,J.L., Backes,B.J., Leonetti,F., Mahrus,S., Ellman,J.A. and Craik,C.S.
    Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries
    Proc Natl Acad Sci U S A97, 7754-7759. PubMed  Europe PubMed DOI  P
  170. Jacobsen,W., Christians,U. and Benet,L.Z.
    In vitro evaluation of the disposition of a novel cysteine protease inhibitor
    Drug Metab Dispos28, 1343-1351. PubMed  Europe PubMed  I
  171. [YEAR:8-12-2000]Roush,W.R., Hernandez,A.A., McKerrow,J.H., Selzer,P.M., Hansell,E. and Engel,J.C.
    Design, synthesis and evaluation of D-homophenylalanyl epoxysuccinate inhibitors of the trypanosomal cysteine protease cruzain
    Tetrahedron56, 9747-9762.  I
  172. [YEAR:3-3-2000]Stoka,V., Turk,B., McKerrow,J.H., Bjork,I., Cazzulo,J.J. and Turk,V.
    The high stability of cruzipain against pH-induced inactivation is not dependent on its C-terminal domain
    FEBS Lett469, 29-32. PubMed  Europe PubMed DOI
  173. Yong,V., Schmitz,V., Vannier-Santos,M.A., de Lima,A.P., Lalmanach,G., Juliano,L., Gauthier,F. and Scharfstein,J.
    Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases
    Mol Biochem Parasitol109, 47-59. PubMed  Europe PubMed DOI
    174. 1999
  174. Serveau,C., Lalmanach,G., Hirata,I., Scharfstein,J., Juliano,M.A. and Gauthier,F.
    Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases
    Eur J Biochem259, 275-280. PubMed  Europe PubMed DOI
    175. 1998
  175. [YEAR:17-8-1998]Engel,J.C., Doyle,P.S., Hsieh,I. and McKerrow,J.H.
    Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection
    J Exp Med188, 725-734. PubMed  Europe PubMed DOI  I
  176. [YEAR:25-9-1998]Lalmanach,G., Lecaille,F., Chagas,J.R., Authie,E., Scharfstein,J., Juliano,M.A. and Gauthier,F.
    Inhibition of trypanosomal cysteine proteinases by their propeptides
    J Biol Chem273, 25112-25116. PubMed  Europe PubMed DOI
  177. [YEAR:6-10-1998]Roush,W.R., Gonzalez,F.V., McKerrow,J.H. and Hansell,E.
    Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain
    Bioorg Med Chem Lett8, 2809-2812. PubMed  Europe PubMed DOI  I
  178. Scheidt,K.A., Roush,W.R., McKerrow,J.H., Selzer,P.M., Hansell,E. and Rosenthal,P.J.
    Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors
    Bioorg Med Chem6, 2477-2494. PubMed  Europe PubMed DOI  I
    179. 1997
  179. Bevec,T., Stoka,V., Pungercic,G., Cazzulo,J.J. and Turk,V.
    A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    FEBS Lett401, 259-261. PubMed  Europe PubMed DOI
  180. Cazzulo,J.J., Stoka,V. and Turk,V.
    Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi
    Biol Chem378, 1-10. PubMed  Europe PubMed
  181. Del Nery,E., Juliano,M.A., Lima,A.P., Scharfstein,J. and Juliano,L.
    Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi
    J Biol Chem272, 25713-25718. PubMed  Europe PubMed DOI
  182. Del Nery,E., Juliano,M.A., Meldal,M., Svendsen,I., Scharfstein,J., Walmsley,A. and Juliano,L.
    Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides
    Biochem J323, 427-433. PubMed  Europe PubMed
  183. Gillmor,S.A., Craik,C.S. and Fletterick,R.J.
    Structural determinants of specificity in the cysteine protease cruzain
    Protein Sci6, 1603-1611. PubMed  Europe PubMed DOI  S  I
  184. Tomas,A.M., Miles,M.A. and Kelly,J.M.
    Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis
    Eur J Biochem244, 596-603. PubMed  Europe PubMed
    185. 1996
  185. Cazzulo,J.J., Bravo,M., Raimondi,A., Engstrom,U., Lindeberg,G. and Hellman,U.
    Hydrolysis of synthetic peptides by cruzipain, the major cysteine proteinase from Trypanosoma cruzi, provides evidence for self-processing and the possibility of more specific substrates for the enzyme
    Cell Mol Biol (Noisy-le-grand)42, 691-696. PubMed  Europe PubMed
  186. Metzner,S.I., Sousa,M.C., Hellman,U., Cazzulo,J.J. and Parodi,A.J.
    The use of UDP-Glc:glycoprotein glucosyltransferase for radiolabeling protein-linked high mannose-type oligosaccharides
    Cell Mol Biol (Noisy-le-grand)42, 631-635. PubMed  Europe PubMed
  187. Serveau,C., Lalmanach,G., Juliano,M.A., Scharfstein,J., Juliano,L. and Gauthier,F.
    Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors
    Biochem J313, 951-956. PubMed  Europe PubMed
    188. 1995
  188. Fish,W.R., Nkhungulu,Z.M., Muriuki,C.W., Ndegwa,D.M., Lonsdale-Eccles,J.D. and Steyaert,J.
    Primary structure and partial characterization of a life-cycle-regulated cysteine protease from Trypanosoma (Nannomonas) congolense
    Gene161, 125-128. PubMed  Europe PubMed DOI
  189. McGrath,M.E., Eakin,A.E., Engel,J.C., McKerrow,J.H., Craik,C.S. and Fletterick,R.J.
    The crystal structure of cruzain: A therapeutic target for Chagas' disease
    J Mol Biol247, 251-259. PubMed  Europe PubMed DOI  S
  190. McKerrow,J.H., McGrath,M.E. and Engel,J.C.
    The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design
    Parasitol Today11, 279-282. PubMed  Europe PubMed
    191. 1994
  191. [YEAR:15-11-1994]Franke de Cazzulo,B.M., Martinez,J., North,M.J., Coombs,G.H. and Cazzulo,J.J.
    Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi
    FEMS Microbiol Lett124, 81-86. PubMed  Europe PubMed DOI  I
  192. Lima,A.P., Tessier,D.C., Thomas,D.Y., Scharfstein,J., Storer,A.C. and Vernet,T.
    Identification of new cysteine protease gene isoforms in Trypanosoma cruzi
    Mol Biochem Parasitol67, 333-338. PubMed  Europe PubMed DOI
  193. North,M.J.
    Cysteine endopeptidases of parasitic protozoa
    Methods Enzymol244, 523-539. PubMed  Europe PubMed DOI  V
  194. Yokoyama-Yasunaka,J.K., Pral,E.M., Oliveira Junior,O.C., Alfieri,S.C. and Stolf,A.M.
    Trypanosoma cruzi: identification of proteinases in shed components of trypomastigote forms
    Acta Trop57, 307-315. PubMed  Europe PubMed DOI
    195. 1993
  195. Eakin,A.E., McGrath,M.E., McKerrow,J.H., Fletterick,R.J. and Craik,C.S.
    Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi
    J Biol Chem268, 6115-6118. PubMed  Europe PubMed
  196. Labriola,C., Sousa,M. and Cazzulo,J.J.
    Purification of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography
    Biol Res26, 101-107. PubMed  Europe PubMed
  197. Martinez,J., Campetella,O., Frasch,A.C. and Cazzulo,J.J.
    The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains
    Immunol Lett35, 191-196. PubMed  Europe PubMed DOI
    198. 1992
  198. Campetella,O., Henriksson,J., Aslund,L., Frasch,A.C., Pettersson,U. and Cazzulo,J.J.
    The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes
    Mol Biochem Parasitol50, 225-234. PubMed  Europe PubMed DOI
  199. Cazzulo,J.J. and Frasch,A.C.
    SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains
    FASEB J6, 3259-3264. PubMed  Europe PubMed
  200. Cazzulo,J.J., Martinez,J., Parodi,A.J., Wernstedt,C. and Hellman,U.
    On the post-translational modifications at the C-terminal domain of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    FEMS Microbiol Lett100, 411-416. PubMed  Europe PubMed
  201. Eakin,A.E., Mills,A.A., Harth,G., McKerrow,J.H. and Craik,C.S.
    The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi
    J Biol Chem267, 7411-7420. PubMed  Europe PubMed
  202. [YEAR:15-8-1992]Martinez,J. and Cazzulo,J.J.
    Anomalous electrophoretic behaviour of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi in relation to its apparent molecular mass
    FEMS Microbiol Lett74, 225-229. PubMed  Europe PubMed
    203. 1991
  203. Aslund,L., Henriksson,J., Campetella,O., Frasch,A.C., Pettersson,U. and Cazzulo,J.J.
    The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    Mol Biochem Parasitol45, 345-347. PubMed  Europe PubMed DOI
  204. McKerrow,J.H.
    New insights into the structure of a Trypanosoma cruzi protease
    Parasitol Today7, 132-133. PubMed  Europe PubMed DOI
  205. Raimondi,A., Wernstedt,C., Hellman,U. and Cazzulo,J.J.
    Degradation of oxidised insulin A and B chains by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi epimastigotes
    Mol Biochem Parasitol49, 341-344. PubMed  Europe PubMed DOI  P
    206. 1990
  206. Bontempi,E. and Cazzulo,J.J.
    Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    FEMS Microbiol Lett58, 337-341. PubMed  Europe PubMed
  207. Cazzulo,J.J., Cazzulo Franke,M.C., Martinez,J. and Franke de Cazzulo,B.M.
    Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi
    Biochim Biophys Acta1037, 186-191. PubMed  Europe PubMed DOI
  208. Greig,S. and Ashall,F.
    Electrophoretic detection of Trypanosoma cruzi peptidases
    Mol Biochem Parasitol39, 31-37. PubMed  Europe PubMed DOI
  209. Murta,A.C., Persechini,P.M., Padron,T., de Souza,W., Guimaraes,J.A. and Scharfstein,J.
    Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase
    Mol Biochem Parasitol43, 27-38. PubMed  Europe PubMed
  210. Souto-Padron,T., Campetella,O.E., Cazzulo,J.J. and de Souza,W.
    Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction
    J Cell Sci96, 485-490. PubMed  Europe PubMed
    211. 1989
  211. Cazzulo,J.J., Couso,R., Raimondi,A., Wernstedt,C. and Hellman,U.
    Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi
    Mol Biochem Parasitol33, 33-41. PubMed  Europe PubMed
    212. 1984
  212. Bontempi,E., Franke de Cazzulo,B.M., Ruiz,A.M. and Cazzulo,J.J.
    Purification and some properties of an acidic protease from epimastigotes of Trypanosoma cruzi
    Comparative Biochemistry and Physiology B77, 599-604. DOI
    213. 1981
  213. Rangel,H.A., Araujo,P.M., Repka,D. and Costa,M.G.
    Trypanosoma cruzi: isolation and characterization of a proteinase
    Exp Parasitol52, 199-209. PubMed  Europe PubMed
    214. 1977
  214. Itow,S. and Camargo,E.P.
    Proteolytic activites in cell extracts of Trypanosoma cruzi
    J Protozool24, 591-595. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use